1-4 of 4
Dirk Elewaut
Close
Sort by
Journal Articles

The Crosstalk Between Leptin Receptor Activation and iNKT Mediated Anti-Tumor Immunity in Multiple Myeloma

Mérédis Favreau, PhDstudent, Eline Menu, PhD, Karin Vanderkerken, PhD, Sylvia Faict, MD, Ken Maes, PhD, Els Van Valckenborgh, PhD, Elke De Bruyne, PhD, Srinath Govindarajan, PhDstudent, Michael Drennan, PhD, Xavier Leleu, Lennart Zabeau, PhD, Jan Tavernier, PhD, Koen Venken, PhD, Dirk Elewaut, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2075.
https://doi.org/10.1182/blood.V128.22.2075.2075
Published: 2016
Journal Articles

Preclinical Evaluation of Invariant Natural Killer T-Cells in the 5T33 Multiple Myeloma Model

Haneen Nur, Sandrine Aspeslagh, PhD, Els Van Valckenborgh, PhD, Elke De Bruyne, PhD, Dirk Elewaut, MD, PhD, Karin Vanderkerken, PhD, Eline Menu, PhD
Journal: Blood
Blood (2012) 120 (21): 938.
https://doi.org/10.1182/blood.V120.21.938.938
Published: 2012
Journal Articles

Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice

Laurens P. Kil, Marjolein J. W. de Bruijn, Menno van Nimwegen, Odilia B. J. Corneth, Jan Piet van Hamburg, Gemma M. Dingjan, Friedrich Thaiss, Guus F. Rimmelzwaan, Dirk Elewaut, Dianne Delsing, Pieter Fokko van Loo, Rudi W. Hendriks
Journal: Blood
Blood (2012) 119 (16): 3744–3756.
https://doi.org/10.1182/blood-2011-12-397919
Published: 2012
Includes: Supplemental data
Journal Articles

Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-β receptor expression

Frederik Stevenaert, Katrien Van Beneden, Veerle De Colvenaer, Ann Sophie Franki, Veronique Debacker, Tom Boterberg, Dieter Deforce, Klaus Pfeffer, Jean Plum, Dirk Elewaut, Georges Leclercq
Journal: Blood
Blood (2005) 106 (3): 956–962.
https://doi.org/10.1182/blood-2004-10-4159
Published: 2005